How Deadly Is a Stroke? Survival and Mortality Rates

Stroke kills roughly 7 million people worldwide each year, making it the second leading cause of death among non-communicable diseases globally.¹ But that headline figure obscures enormous variation. Whether a stroke is survivable depends on its type, its severity, how quickly treatment begins, and the overall health of the person who has it. Some strokes are mild enough that a person walks out of the hospital within days. Others are fatal within hours. Understanding where any individual case falls on that spectrum requires knowing which factors push the odds in which direction.

The Two Types of Stroke Have Very Different Death Rates

About 85% of strokes are ischemic, caused by a blood clot blocking an artery to the brain. The remaining 15% are hemorrhagic, caused by a blood vessel rupturing and bleeding into or around the brain. That distinction matters enormously for survival. Hemorrhagic strokes arrive with more severe symptoms on average, require longer hospital stays, and carry a substantially higher risk of death. One study comparing the two types found overall mortality was about 43% for hemorrhagic stroke patients versus 30% for ischemic stroke patients.²

The timing of that risk gap is worth knowing. In the first days after a stroke, the mortality risk from a hemorrhagic stroke is roughly four times higher than from an ischemic stroke. By one week, the gap narrows to about two-and-a-half-fold. By three weeks, the elevated risk is only one-and-a-half times higher. After about three months, the type of stroke no longer predicts mortality on its own.³ In other words, hemorrhagic strokes are far more dangerous in the acute phase, but if someone survives the first few months, the long-term outlook converges with that of ischemic stroke survivors.

For hemorrhagic stroke specifically, in-hospital mortality hovers around 28% to 32% across multiple studies, and one-year mortality reaches roughly 45%.⁴ Among the strongest predictors of death after a brain bleed is the ICH score, a clinical grading tool that accounts for factors like the size and location of the bleed and the patient’s level of consciousness at arrival.⁵ Patients on blood thinners like warfarin at the time of the bleed also face higher in-hospital death rates, while certain antiplatelet medications appeared to have a protective effect in at least one analysis.

What Happens Over Five Years

Survival statistics grow grimmer the further out you look. One community-based study found that the risk of dying in the first year after a stroke was about 37%, which was ten times higher than the expected death rate for people of the same age and sex who had not had a stroke.⁶ Between years one and five, the annual risk of death settled to roughly 10% per year, which was still about double the expected rate for the general population. By five years, about 58% of all first-ever stroke patients in that study had died.

Other cohort studies report broadly similar findings. One found a cumulative five-year survival rate of 29%, with ischemic stroke patients faring somewhat better than hemorrhagic ones (31% versus 24% alive at five years).⁷ Another study reported five-year survival of about 42% overall, with ischemic stroke patients again outliving hemorrhagic ones (45% versus 27%).⁸ The variation between studies partly reflects differences in the populations studied, the era of treatment, and the availability of acute care. But the pattern is consistent: stroke takes a heavy toll that extends well beyond the initial event.

An interesting wrinkle shows up in the long-term data for people who survive the first month. Among 30-day survivors, those who originally had a hemorrhagic stroke actually had better five-year survival rates than ischemic stroke survivors (57% versus about 43%).⁷ This probably reflects a selection effect: surviving a hemorrhagic stroke’s dangerous early phase may indicate a stronger baseline constitution, while ischemic stroke patients often have underlying cardiovascular disease that continues to threaten them over the following years.

What Stroke Survivors Actually Die From

The initial stroke itself is the leading cause of death in the first month, accounting for about half of all deaths during that period. But as time passes, the causes of death shift. In the first year after a cerebral infarction, cardiovascular disease (heart attacks, heart failure) and respiratory infections each caused roughly a quarter of deaths.⁹ Recurrent stroke accounted for about 9% of deaths, and cancer for about 8%. Over the longer term, cardiovascular events became the single most common killer.

This means that surviving a stroke does not return you to normal life expectancy. The same vascular damage and risk factors that caused the first stroke continue working in the background. And a second stroke, when it comes, carries even worse odds. A large Danish registry study found that one-year mortality after a first ischemic stroke was about 17%, but after a recurrent ischemic stroke it climbed to 25%. By ten years, mortality after a first stroke reached 56%, while after a recurrent stroke it reached 70%.¹⁰ For hemorrhagic stroke, one-year mortality was 37% after a first event.

How Age Shapes the Odds

Age is one of the strongest predictors of dying from a stroke, though the relationship is not as simple as “older always means worse.” In a multicenter Canadian study, discharge case fatality roughly quadrupled from about 6% for patients under 59 to about 24% for those 80 and older.¹¹ Among people over 80, each five-year age bracket brought notably shorter survival times, with median survival dropping from about two years for those aged 80-84 to about seven months for those in their early nineties.¹²

But here is a surprising finding: in the very earliest days after a severe stroke, the death rate does not simply keep climbing in the oldest age groups. One study found that for severe strokes, the three-day death rate increased up to about age 75 and then leveled off or even declined slightly with further advancing age.¹³ The researchers concluded that advanced age alone should not be treated as an automatic disadvantage in the very acute phase of stroke. The likely explanation is survivorship bias: people who reach their late eighties and nineties tend to be biologically resilient in ways that help them weather the immediate crisis, even though their overall life expectancy post-stroke is shorter. For one-month case fatality, however, the climbing pattern held across all ages.

Five-year survival data reflects the expected age gradient more starkly. Among stroke patients 50 and younger, five-year survival was about 57%, while for those over 70 it dropped to roughly 9%.⁷

Sex Differences in Stroke Outcomes

Women bear a disproportionate burden of stroke mortality and disability worldwide.¹⁴ At first glance, this looks like a biological disadvantage. But the picture is more complicated. Women tend to have their first stroke at an older age than men, and they arrive at the hospital with worse baseline function on average. Those pre-existing differences in age and functional status account for much of the gap in outcomes.¹⁵

When researchers adjust for age and other confounders, the survival picture actually flips. A large data-linkage study found that after adjustment, women had lower one-year mortality than men for both ischemic and hemorrhagic stroke.¹⁶ That same study, though, found gaps in the quality of care women received: women were less likely to be prescribed blood-pressure medications, cholesterol-lowering drugs, and blood thinners after discharge, and after a hemorrhagic stroke they were less likely to receive all components of the recommended care bundle. These prescribing gaps could partly offset the biological survival advantage.

Treatment Dramatically Changes the Odds

One of the most consistent findings in stroke research is that where and how quickly you receive treatment matters almost as much as the stroke itself. Dedicated stroke units have repeatedly been shown to improve survival compared to general hospital wards. In one randomized trial, death within the first ten days was 8% in the stroke unit group versus 15% in general medical wards. At one year, survival was about 71% for stroke unit patients versus 65% for those treated on regular wards.¹⁷ This survival benefit persisted at five years, when about 59% of stroke unit patients had died compared to 71% of those treated on general wards.¹⁸ A community-based study found that stroke units cut in-hospital mortality roughly in half and significantly reduced six-month and one-year mortality as well.¹⁹

For ischemic strokes caused by large blood clots blocking a major brain artery, mechanical thrombectomy (physically removing the clot via catheter) has emerged as one of the most effective acute interventions. A meta-analysis of randomized trials found that thrombectomy combined with standard medical therapy lowered the three-month mortality rate to about 15%, compared to about 19% with medical therapy alone.²⁰ The benefits were even more striking for functional outcomes, with more patients achieving independence after treatment.

Clot-dissolving drugs (thrombolytics) given intravenously remain the first-line treatment for ischemic stroke, though the time window in which they work is narrow. In the landmark EXTEND trial, patients treated with the clot-dissolving drug alteplase up to nine hours after stroke onset had a significantly better chance of a good functional outcome than those given placebo, though there was a higher rate of brain bleeding as a side effect.²¹ Across multiple meta-analyses of extended-window thrombolysis, mortality at 90 days did not significantly differ between treated and untreated groups, suggesting that the drugs improve disability outcomes without a clear penalty in deaths.²² For patients with clots in the basilar artery at the back of the brain, combining thrombolytic drugs with mechanical thrombectomy reduced 90-day mortality compared to thrombectomy alone.²³

Why Getting to the Hospital Fast Matters So Much

The phrase “time is brain” exists for a reason. Every minute a large-vessel ischemic stroke goes untreated, an estimated 1.9 million neurons die. Treatments like thrombolytics and thrombectomy are most effective when administered early, and their benefit diminishes with each passing hour. Yet getting patients to treatment quickly remains a challenge. A large study of emergency medical services response in Florida found that the median time from the emergency call to hospital arrival was about 34 minutes, and fewer than two-thirds of encounters met the recommended time benchmarks.²⁴ When dispatchers flagged a suspected stroke or paramedics used a stroke assessment checklist, response times were modestly but significantly shorter.

For people witnessing a possible stroke, the practical takeaway is straightforward: call emergency services immediately. The most recognizable warning signs are sudden one-sided weakness, difficulty speaking, and a drooping face, but severe headache, vision loss, or sudden confusion also warrant an emergency call. Delays in seeking help are one of the most preventable contributors to stroke death and disability.

The Role of Existing Health Conditions

Stroke rarely strikes in a vacuum. The coexisting conditions a person carries into the event substantially shape their chances of survival. Diabetes is a particularly potent modifier. Among patients with atrial fibrillation (a common heart rhythm disorder that raises stroke risk), those who also had diabetes had about a 25% higher risk of dying over the follow-up period than those without diabetes, and their risk of having a stroke in the first place was about a third higher.²⁵

Atrial fibrillation itself is worth singling out. Strokes that occur in the setting of this irregular heart rhythm tend to be more severe and carry a grimmer prognosis. One study found that median survival after a stroke in patients with atrial fibrillation was only about 1.8 years, compared to 5.7 years for matched individuals of similar age and health who had not had a stroke. For those with severe stroke-related deficits, the risk of death was more than eight times higher than for matched comparators without stroke.²⁶ The severity of the stroke itself was a powerful predictor of long-term survival, more so than most other clinical variables.

Declining Death Rates Over Decades

Despite the grim statistics for individual patients, the broader trend in stroke mortality has been strongly positive. In the United States, the age-adjusted stroke death rate fell by about 82% between 1970 and 2023, from 177 per 100,000 people to 32 per 100,000.²⁷ Ischemic stroke mortality dropped by 81% and hemorrhagic stroke mortality by 86% over the same period. The steepest declines occurred during the 1970s and the early 2000s, periods that coincided with improved blood-pressure control and advances in acute stroke care.

This progress has not been perfectly smooth or evenly distributed. Between roughly 2013 and 2015, the decline in stroke death rates stalled, and in some subgroups it reversed. Among Hispanic Americans, stroke death rates increased by nearly 6% per year during that stretch. In the southern United States, rates also rose. Researchers estimated that roughly 32,600 excess stroke deaths may have occurred because of these unfavorable changes in the rate of decline.²⁸ A separate longer-term analysis confirmed that age-adjusted stroke mortality among Black Americans remained the highest of any racial group throughout the entire period from 1970 to 2023.²⁷

Geography and Income Shape Who Survives

Where in the world a stroke happens may matter as much as the stroke itself. A meta-analysis covering more than 8,500 patients in low-income and lower-middle-income countries found a pooled in-hospital mortality rate of about 20%. For ischemic strokes specifically, the in-hospital death rate was around 13%, compared to about 3% to 7% in large U.S. and German databases. For hemorrhagic strokes, the gap was similar: about 27% in poorer countries versus roughly 18% in wealthier ones.²⁹ Limited access to imaging, clot-dissolving drugs, thrombectomy-capable hospitals, and dedicated stroke units drives much of this disparity.

Within wealthy countries, socioeconomic disparities persist too. A study of men in North Carolina found that among both Black and white men, those in the lowest social class had nearly three times the rate of premature stroke death compared to those in the highest. And within every social class, Black men had four to five times the premature stroke death rate of white men.³⁰ These disparities reflect differences in access to preventive care, control of risk factors like hypertension, and proximity to hospitals equipped for acute stroke treatment.

Disability Is Part of the Survival Story

Focusing only on whether someone lives or dies after a stroke misses a large part of the picture. Stroke is the third leading cause of death and disability combined worldwide, accounting for more than 160 million disability-adjusted life years lost each year.¹ That metric captures not just years of life lost to premature death, but also years lived with significant impairment. Many stroke survivors face lasting challenges with movement, speech, cognition, or emotional regulation that fundamentally alter their quality of life.

The data bears this out in concrete terms. Among hemorrhagic stroke survivors, the average disability scores remained significantly worse than those of ischemic stroke survivors even beyond twelve months after the event.² Only about one in five hemorrhagic stroke patients in one study were discharged directly home from the hospital, compared to about one in three ischemic stroke patients. For the many survivors who end up in rehabilitation facilities or nursing homes, the road back to independent living can be long, and for some it never fully arrives. The disability-adjusted life years framework was developed in part because of diseases like stroke, which disables at least as powerfully as it kills.³¹

End-of-Life Decisions and How They Complicate the Numbers

One factor that rarely comes up in public discussions of stroke mortality is the role of early do-not-resuscitate (DNR) orders. When a stroke is judged to be devastating, families and medical teams sometimes make the decision to withdraw aggressive treatment early on. These decisions are deeply personal and often medically reasonable, but they create a statistical wrinkle: hospitals with higher rates of early DNR orders for stroke patients tend to show higher mortality rates, which may not accurately reflect the quality of care those hospitals provide.³² The variation in DNR practices across hospitals is wide, and until the circumstances behind these orders are better understood, raw mortality comparisons between hospitals can be misleading. For families navigating a severe stroke, it is worth knowing that the mortality statistics they encounter online may partly reflect these care-preference decisions rather than purely medical inevitability.